BSB, I agree the balance sheet is an issue that would cause many serious investors to pass. Biotech is risky without having to worry about a company with the liquidity of s homeless person.
I disagree that Sawston brings in that much. There are 3 notes and a toxic waste liability attached to it.
They again rolled the 12% mortgages for another year, and paid 3% to do so. That implies to me they can not pull the equity out via a refinance, else why pay these rates?
And everybody here has convinced me that LP will not sell.
Market Data 
Markets 
AI
